Pharmaceutical Composition for the Treatment of Type 1-Diabetes
AssigneeQinghua Wang
InventorsQinghua WANG, Soltani NEPTON
Life of this patent
Estimating the term…
Abstract
A composition for the prevention or treatment of type I diabetes in a subject, said composition comprising a GABAergic and incretin exemplified by GABA and GLP-1/Ex4. These are optionally provided together in a single composition to promote beta-cell regeneration prevent beta-cell apoptosis and control autoimmunity for the prevention and treatment of T1D in mammals.
Claims20
A method of treating type 1 diabetes (T1D), said method comprising administering to a subject having T1D a therapeutically effective amount of a composition comprising a GABAergic compound, or a pharmaceutically acceptable salt thereof.
A composition, comprising a GABAergic compound and an incretin and optionally a pharmaceutically suitable carrier.
Dependencies are inferred from the claim text.